Hepatic Cell News Volume 7.36 | Sept 29 2023

    0
    57








    2023-09-29 | HCN 7.36


    Hepatic Cell News by STEMCELL Technologies
    Vol. 7.36 – 29 September, 2023
    TOP STORY

    Interaction between Estrogen Receptor-α and PNPLA3 p.I148M Variant Drives Fatty Liver Disease Susceptibility in Women

    Scientists showed that there was a specific multiplicative interaction between female sex and patatin-like phospholipase domain-containing 3 (PNPLA3) p.I148M in determining fatty liver disease in at-risk individuals (steatosis and fibrosis, and advanced fibrosis/HCC) and in the general population.
    [Nature Medicine]

    Full ArticlePress Release
    Explore the Science Events Calendar to discover conferences, podcasts, webinars, and more!
    PUBLICATIONSRanked by the impact factor of the journal

    Combined FOLFOX4 with All-Trans Retinoic Acid versus FOLFOX4 with Placebo in Treatment of Advanced Hepatocellular Carcinoma with Extrahepatic Metastasis: A Randomized, Double-Blind Comparative Study

    In this randomized, double-blind, placebo-controlled study, investigators assessed the efficacy and safety of FOLFOX4 with all-trans-retinoic acid as a palliative treatment for HCC patients with extrahepatic metastasis, compared to FOLFOX4 with a placebo.
    [Signal Transduction and Targeted Therapy]

    Full Article

    SCARB2 Drives Hepatocellular Carcinoma Tumor Initiating Cells via Enhanced MYC Transcriptional Activity

    Scientists performed a metabolic gene CRISPR/Cas9 knockout library screen in tumorspheres derived from HCC cells and found that deletion of scavenger receptor class B member 2 (SCARB2) suppressed the cancer stem cell-like properties of HCC cells.
    [Nature Communications]

    Full Article

    Long-Term Major Adverse Liver Outcomes in 1,260 Patients with Non-Cirrhotic NAFLD

    Researchers conducted a cohort study with data from Swedish university hospitals. Patients with nonalcoholic fatty liver disease (NAFLD) without cirrhosis were diagnosed through biopsy or radiology, and had fibrosis estimated.
    [JHEP Reports]

    Full Article

    MAD2 Activates IGF1R/PI3K/AKT Pathway and Promotes Cholangiocarcinoma Progression by Interfering USP44/LIMA1 Complex

    Investigators found up-regulated mitotic arrest deficient 2 (MAD2) facilitated cholangiocarcinoma progression and induced lymphatic metastasis dependent on USP44/LIMA1/PI3K/AKT pathway.
    [Oncogene]

    Abstract

    LncRNA NEAT1 Suppresses Cellular Senescence in Hepatocellular Carcinoma via KIF11-Dependent Repression of CDKN2A

    The role of nuclear enriched abundant transcript 1 (NEAT1) and kinesin family member 11 (KIF11) in cellular senescence and tumor growth in HCC was assessed both in vitro and in vivo.
    [Clinical and Translational Medicine]

    Full Article

    CARD9 Deficiency Aggravated Nonalcoholic Steatohepatitis in Mice through Increasing Inflammatory Response

    The authors investigated the role of caspase recruitment domain family member 9 (CARD9) in the development of nonalcoholic steatohepatitis (NASH). NASH models were established using CARD9-knockout and wild-type mice.
    [Biochimica Et Biophysica Acta-Molecular Basis Of Disease]

    Abstract

    The Anti-Hepatocellular Carcinoma Effect of Aidi Injection Was Related to the Synergistic Action of Cantharidin, Formononetin, and Isofraxidin through BIRC5, FEN1, and EGFR

    The anti-HCC effect of aidi injection was evaluated in various HCC cells and the zebrafish xenograft model.
    [Journal of Ethnopharmacology]

    Full ArticleGraphical Abstract

    Glucagon-Like Peptide-1 and Glucagon-Like Peptide-2 Regulation during Human Liver Regeneration

    Researchers evaluated potential alterations and dynamics of circulating glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2) in patients undergoing liver resections, focusing on post-hepatectomy liver failure.
    [Scientific Reports]

    Full Article

    Hepatocyte-Specific HDAC3 Ablation Promotes Hepatocellular Carcinoma in Females by Suppressing Foxa1/2

    Constitutively hepatocyte-specific histone deacetylase 3 (HDAC3)-deficient mice and constitutively hepatocyte-specific HDAC3 knockout and systemic interleukin-6 simultaneously ablated mice were used to explore the causes of sex differences in HCC.
    [BMC Cancer]

    Full Article
    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    REVIEWS

    Bioactive Signaling Lipids as Drivers of Chronic Liver Diseases

    The authors focus specifically on the bioactive lipids derived from phospholipids and poly-unsaturated fatty acids in the prevalent chronic hepatopathies.
    [Journal of Hepatology]

    Full Article
    INDUSTRY AND POLICY NEWS

    USC Launches Liver Disease Study as Part of $50.3 Million “Multi-Omics” Consortium

    The Keck School of Medicine of the University of South Carolina (USC) has received funding from the National Institutes of Health as part of a five-year, $50.3 million “multi-omics” study of human health and disease involving six sites.
    [University of South Carolina]

    Press Release
    FEATURED EVENT

    Cell 2023

    November 7 – 8, 2023
    London, England, United Kingdom

    > See All Events

    JOB OPPORTUNITIES

    Research Assistant – Department of Medicine

    National University of Singapore – Singapore, Singapore

    Faculty Positions – Cancer Research

    Houston Methodist Research Institute – Houston, Texas, United States

    Postdoctoral Fellow – Tissue Regeneration and Clonal Evolution

    Francis Crick Institute – London, England, United Kingdom

    Clinical/Non-Clinical Senior Lecturer – Experimental Medicine

    King’s College London – London, England, United Kingdom

    Professor – Clinical Pediatrics

    University of South California – Los Angeles, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter